You are here

ReVance

AbbVie's Botox patent lawsuit is 'very unlikely to derail' Revance's rival launch: analysts

Fierce Pharma

Mon, 10/11/21 - 09:46 pm

Aji Bio-Pharma and Revance in manufacturing deal for anti-wrinkle rival to Botox

Biopharma Reporter

Tue, 12/22/20 - 10:51 am

drug manufacturing

daxiabotulinumtoxinA

Revance's frown-line injection latest to face regulatory delay after FDA can't hit inspection deadline

Fierce Pharma

Mon, 11/30/20 - 11:20 pm

daxibotulinumtoxinA

The Week Ahead In Biotech: Moderna Vaccine And Roche, Revance, Rhythm, Liquidia FDA Updates

Yahoo/Benzinga

Sun, 11/22/20 - 11:53 pm

Moderna Therapeutics

Rhythm Pharmaceuticals

Mylan teams up with Revance on biosimilar for Botox

Reuters

Thu, 03/1/18 - 11:53 pm

Settle down, Allergan investors. Botox's market share is safe, analysts say

Fierce Pharma

Wed, 12/6/17 - 11:11 am

wrinkle treatment

Watch out Allergan: Revance’s wrinkle-reducer beats Botox in PhIII trials

Endpoints

Tue, 12/5/17 - 09:31 am

clinical trials

wrinkle treatments

Revance Therapeutics IPO May Make You Look Good

Seeking Alpha

Thu, 02/6/14 - 09:54 am

Eager biotechs crowd into Wall Street this week with $500M in IPO pitches

Fierce Biotech

Tue, 02/4/14 - 07:06 pm

Eleven Biotherapeutics

Medicis hands back next-gen botox rights, settles up with Revance

Fierce Biotech

Mon, 10/8/12 - 12:29 pm

Valeant Pharmaceuticals

Medicis Sued By Revance Therapeutics Over Wrinkle-Gel Pact

Bloomberg

Mon, 05/28/12 - 11:22 am

Medicis (MRX) and ReVance Therapeutics, Inc. Announce Agreement for Development of Next-Gen Neurotoxin; Revance to Receive $10M

Fierce Biotech

Wed, 07/29/09 - 11:21 am